- Home
- About Us
- Our Clients
- Our Cases
- CVS
- Johnson & Johnson
- Leo Burnett
- Merck & Co.
- Northrop-Grumman
- Omnicare Kickbacks
- Omnicare Switching
- Par
- University of Chicago Medical Center
- Walgreens
- - CBS News Report
- - News Release
- - Case - Summary
- - Federal Press Release
- - Complaint
- - Federal Settlement Agreement
- - Participating States
- - NAMFCU Release
- - Arizona Settlement
- - Florida Release
- - Illinois Release
- - Indiana Release
- - Michigan Settlement
- - The Drugs
- - Company News Release
- - The Company
- Being a Whistleblower
- Types of FCA Cases
- False Claims Act Laws
- Contact Us
Whistleblower Action Network Attorneys and Cases Educate, Make Strides
Whistleblower Action Network Attorney Tim Terry gave a presentation regarding the provisions and applications of the Federal and Nevada False Claims Act to the 2011 Nevada Government Civil Attorneys Conference at Lake Tahoe in May. Efforts like this vastly improve the utility of the False Claims Act by arming as many attorneys with powerful information as possible.
Behn and Wyetzner move forward in their case against Johnson and Johnson with the most recent motion for reconsideration being denied, thanks to provisions in the False Claims Act that ensure first to filed claims that are unique from previous cases are considered. View the .pdf of the opinion here.
Department of Health and Human Services Inspector General Daniel R. Levinsonan referenced the Johnson and Johnson case in a note about a major report regarding hundreds of thousands of eld erly nursing home residents who may have been overmedicated with dementia drugs. Cases like the Johnson and Johnson case uncovered kickbacks that induced Omnicare, the nation's largest long-term care pharmacy, to recommend the use of Risperdal in treating nursing home patients, many of whom had dementia.
- wanadmin's blog
- Login or register to post comments



